(Q45163318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

12

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

5

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

8

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

10

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

7

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

6

Takashi Someya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Akihito Tsubota

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

362-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

5 January 2020

cites work

1 reference

Histological outcome during long-term lamivudine therapy.

21 January 2018

1 reference

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

21 January 2018

1 reference

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy

21 January 2018

1 reference

Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy

21 January 2018

1 reference

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy

21 January 2018

1 reference

New acquisitions in the development of anti-HIV agents

21 January 2018

1 reference

Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication

21 January 2018

1 reference

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

21 January 2018

1 reference

A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

21 January 2018

1 reference

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

21 January 2018

1 reference

Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.

21 January 2018

1 reference

Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure

21 January 2018

1 reference

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

21 January 2018

1 reference

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product

21 January 2018

1 reference

Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells

21 January 2018

1 reference

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

21 January 2018

1 reference

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

21 January 2018

1 reference

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15564749%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference